CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients.

Ruben A G van EerdenNikki S IJzermanMilan van MeekerenEsther Oomen-de HoopNiels A D GuchelaarAndrea M W VisserMaja MaticRon H N van SchaikPeter de BruijnDirk-Jan A R MoesPieter A JobseHans GelderblomAlwin D R HuitemaNeeltje SteeghsRon H J MathijssenStijn L W Koolennull null

Published in: Clinical pharmacokinetics (2023)

International Clinical Trials Registry Platform Search Portal; number NL7514; registered 11/02/2019.

Keyphrases

clinical trial
high throughput
phase ii
open label
double blind
phase iii
randomized controlled trial
placebo controlled